Page 46 - Unity Lab Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing New Carlsbad, California cGMP site will accelerate commercialization of plasmid-based medicines and vaccines News provided by Share this article Share this article WALTHAM, Mass., Dec. 16, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to devel...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Direct from Saliva PCR Test for COVID-19 Enables Fast, Low-Cost Results for High-Frequency Surveillance Testing at Colleges and Universities December 10, 2020 GMT CARLSBAD, Calif., Dec. 10, 2020 /PRNewswire/ -- Thermo Fisher Scientific announced today the availability of a new direct from saliva PCR test for COVID-19 to enable widespread, high-frequency surveillance testing. The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples and simplifies lab workflows using instruments ...

Search jobs Thermo Fisher Scientific Gains CE Mark Certification for New OmniPATH Combi SARS-CoV-2 IgG ELISA Test Thermo Fisher Scientific, the world leader in serving science, has secured CE Mark certification for the Thermo Scientific OmniPATH Combi SARS-CoV-2 IgG ELISA test. The test is intended for the quantitative measurement of immunoglobulin G (IgG) antibodies raised against the spike protein of the SARS-CoV-2 virus to aid clinicians in identifying patients with an immune response pre- and post-vaccination. The ability to quantify IgG is a critical component t...

Thermo Fisher to Expand in Greenville, Add 500 New Jobs Thermo Fisher Scientific, a global life science services company with major operations in North Carolina, will add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. The investment, approximately $500 million, will include a new, stand-alone, 130,000-square-foot facility with two live- virus filling lines that will be operational in 2022. The site will also add six new lines in 2021 and 2022, including commercia...

by Barry Teater, NCBiotech Center — December 10, 2020 . RESEARCH TRIANGLE PARK – Thermo Fisher Scientific, a global life science services company with major operations in North Carolina, will add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. The investment, approximately $500 million, will include a new, stand-alone, 130,000-square-foot facility with two live- virus filling lines that will be operational in 2022. The site will also add six new lines in 2021...